ESR1 and breast carcinoma: For breast cancer, the analysis of multiple breast cancer cohorts indicated that high SPAG5 transcript expression was associated with decreased survival in all breast cancer subtypes and estrogen receptor-positive subgroups; although, its prognostic value in TNBC was not clear [7].